Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? - PubMed (original) (raw)
Review
Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?
Vanessa A Rodie et al. Atherosclerosis. 2004 Aug.
Abstract
Complications of pregnancy, particularly pre-eclampsia (PET) and intra-uterine growth restriction (IUGR) have been associated with future maternal cardiovascular disease (CVD). Pre-eclampsia, characterised by insulin resistance, widespread endothelial damage and dysfunction, coagulation defects and increased systemic inflammatory response, shares many risk factors with CVD. This review describes the pathology of PET and the maternal metabolic response and discusses the possible underlying mechanisms common to CVD and PET. The contributions of pre-existing risk factors and of the exaggerated atherogenic-like response seen in PET persisting post-partum to future CVD are considered. The potential for interventions based on early assessment of cardiovascular risk is addressed. We conclude that despite the low immediate cardiovascular risk in a population of young women, a pregnancy with multiple complications including PET, premature delivery and IUGR, carries a seven-fold additive risk of future disease. These women may be an appropriate cohort for CVD risk screening and for possible intervention.
Copyright 2004 Elsevier Ireland Ltd
Similar articles
- Induction of labour or expectant monitoring in hypertensive pregnancy disorders at term: do women's postpartum cardiovascular risk factors differ between the two strategies?
Hermes W, Koopmans CM, van Pampus MG, Franx A, Bloemenkamp KW, van der Post J, Porath M, Tamsma JT, Mol BW, de Groot CJ. Hermes W, et al. Eur J Obstet Gynecol Reprod Biol. 2013 Nov;171(1):30-4. doi: 10.1016/j.ejogrb.2013.08.006. Epub 2013 Aug 11. Eur J Obstet Gynecol Reprod Biol. 2013. PMID: 24011382 Clinical Trial. - Ante-partum and post-partum markers of metabolic syndrome in pre-eclampsia.
Lei Q, Lv LJ, Zhang BY, Wen JY, Liu GC, Lin XH, Niu JM. Lei Q, et al. J Hum Hypertens. 2011 Jan;25(1):11-7. doi: 10.1038/jhh.2010.29. Epub 2010 Mar 11. J Hum Hypertens. 2011. PMID: 20220770 - Pre-eclampsia and Cardiovascular Disease Risk Assessment in Women.
Murphy MS, Smith GN. Murphy MS, et al. Am J Perinatol. 2016 Jul;33(8):723-31. doi: 10.1055/s-0036-1572536. Epub 2016 Mar 31. Am J Perinatol. 2016. PMID: 27031056 Review. - Postpartum evaluation and long term implications.
Firoz T, Melnik T. Firoz T, et al. Best Pract Res Clin Obstet Gynaecol. 2011 Aug;25(4):549-61. doi: 10.1016/j.bpobgyn.2011.03.003. Epub 2011 May 4. Best Pract Res Clin Obstet Gynaecol. 2011. PMID: 21536498 Review. - Preeclampsia and cardiovascular risk.
Hermes W, Van Kesteren F, De Groot CJ. Hermes W, et al. Minerva Ginecol. 2012 Aug;64(4):281-92. Minerva Ginecol. 2012. PMID: 22728573 Review.
Cited by
- Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis.
Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Brown MC, et al. Eur J Epidemiol. 2013 Jan;28(1):1-19. doi: 10.1007/s10654-013-9762-6. Epub 2013 Feb 9. Eur J Epidemiol. 2013. PMID: 23397514 Review. - An RGS2 3'UTR polymorphism is associated with preeclampsia in overweight women.
Karppanen T, Kaartokallio T, Klemetti MM, Heinonen S, Kajantie E, Kere J, Kivinen K, Pouta A, Staff AC, Laivuori H. Karppanen T, et al. BMC Genet. 2016 Aug 24;17(1):121. doi: 10.1186/s12863-016-0428-8. BMC Genet. 2016. PMID: 27558088 Free PMC article. - Challenges of studying drugs in pregnancy for off-label indications: pravastatin for preeclampsia prevention.
Cleary KL, Roney K, Costantine M. Cleary KL, et al. Semin Perinatol. 2014 Dec;38(8):523-7. doi: 10.1053/j.semperi.2014.08.019. Epub 2014 Oct 12. Semin Perinatol. 2014. PMID: 25315293 Free PMC article. Review. - Stroke in Pregnancy: A Multidisciplinary Approach.
Camargo EC, Singhal AB. Camargo EC, et al. Obstet Gynecol Clin North Am. 2021 Mar;48(1):75-96. doi: 10.1016/j.ogc.2020.11.004. Obstet Gynecol Clin North Am. 2021. PMID: 33573791 Free PMC article. Review. - An observational claims data analysis on the risk of maternal chronic kidney disease after preterm delivery and preeclampsia.
Goetz M, Müller M, Gutsfeld R, Dijkstra T, Hassdenteufel K, Brucker SY, Bauer A, Joos S, Colombo MG, Hawighorst-Knapstein S, Chaudhuri A, Kirtschig G, Saalmann F, Wallwiener S. Goetz M, et al. Sci Rep. 2021 Jun 15;11(1):12596. doi: 10.1038/s41598-021-92078-2. Sci Rep. 2021. PMID: 34131246 Free PMC article.